High-Quality Pharmacy Grade Gliclazide Powder CAS 21187-98-4

A vital oral antihyperglycemic agent for effective Type 2 diabetes management.

Get a Quote & Sample

Key Advantages Offered

Enhanced Glycemic Control

Leveraging the precise mechanism of sulfonylurea hypoglycemic agents, Gliclazide effectively stimulates pancreatic beta cells to release insulin, leading to better blood glucose regulation.

Cardiovascular Protection

Gliclazide's ability to reduce platelet aggregation and prevent fibrin deposition in microvasculature contributes to preventing the development and progression of diabetes-related blood vessel complications.

Comprehensive Health Benefits

This compound also aids in lowering cholesterol and plasma triglycerides, offering a multifaceted approach to managing metabolic disorders alongside its primary hypoglycemic effect.

Key Applications

Type 2 Diabetes Management

As a leading oral antihyperglycemic agent, Gliclazide powder is widely used to treat hyperglycemia in stable, mild cases of Type 2 diabetes when diet and exercise are insufficient.

Preventing Diabetic Complications

Its beneficial effects on blood vessels make it crucial for preventing the progression of diabetic retinopathy, nephropathy, and other microvascular issues.

Improving Insulin Sensitivity

Gliclazide enhances the sensitivity of target tissues to insulin, complementing its direct role in insulin secretion for a more robust glycemic control.

Pharmaceutical Formulations

The high-quality pharmacy grade gliclazide powder serves as a critical Active Pharmaceutical Ingredient (API) in the manufacturing of various oral antidiabetic medications.